Mon, 21 Sep 2020 12:20:34: Flagship Pioneering's 2-becomes-one biotech nabs ex-Pfizer CSO as research lead

Mon, 21 Sep 2020 12:03:57: Bischofberger's Kronos files for IPO to run pivotal cancer trial

Mon, 21 Sep 2020 12:03:45: ESMO: Blueprint preps trial of drug targeting triple-mutant EGFR in lung cancer backed by mouse data

Mon, 21 Sep 2020 11:09:23: ESMO: Adding Elevar's EGFR drug to AstraZeneca's Iressa boosts survival in early lung cancer

Mon, 21 Sep 2020 10:18:28: Boosting immuno-oncology drugs by recruiting immune messenger cells

Mon, 21 Sep 2020 09:42:34: Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position in hot field 

Fri, 18 Sep 2020 15:44:00: ESMO: Roche's Akt inhibitor scores slight win over J&J's Zytiga

Fri, 18 Sep 2020 15:36:55: ESMO: Novartis posts data from failed spartalizumab phase 3, reaffirms commitment to PD-1 combos

Fri, 18 Sep 2020 15:24:52: ESMO: Chi-Med's surufatinib gears up to challenge Novartis, Pfizer with placebo-topping phase 3

Fri, 18 Sep 2020 13:50:31: ESMO: Early days, but Amgen's BiTE drug in prostate cancer shows encouraging activity

Fri, 18 Sep 2020 12:23:55: Under pressure, Pfizer, Moderna (and soon AstraZeneca) publish COVID-19 vaccine protocols

Fri, 18 Sep 2020 11:58:54: Roden, fresh from BMS-Celgene merger, lands VC role at MPM

Fri, 18 Sep 2020 09:56:28: Brii hires Gilead's China general manager Luo to drive expansion

Fri, 18 Sep 2020 07:16:22: ESMO: Alkermes' major I-O hope sees progress across early cancer tests

Thu, 17 Sep 2020 18:40:42: Chutes & Ladders—Olema Oncology brings on AstraZeneca vet Bohen as CEO

Thu, 17 Sep 2020 14:14:33: ESMO: Amunix's T-cell engagers shrink solid tumors in animal models

Thu, 17 Sep 2020 12:19:20: Novo, Sanofi VC units lead Lava's $83M series C to fund gamma delta T-cell trials

Thu, 17 Sep 2020 10:33:01: Moderna lands $100M upfront in deals with Vertex, Chiesi

Thu, 17 Sep 2020 07:53:36: Trials 'unable to bounce back' after COVID-19 chaos: report

Thu, 17 Sep 2020 07:09:05: AstraZeneca nabs next-gen oral PCSK9 inhibitor asset from Dogma Therapeutics

Wed, 16 Sep 2020 13:48:41: Covance teams up with Tempus with time on its mind

Wed, 16 Sep 2020 12:16:42: Lilly links COVID-19 antibody to reduced hospitalization rate

Wed, 16 Sep 2020 11:28:45: AstraZeneca's COVID-19 vaccine adverse event has NIH 'very concerned'

Wed, 16 Sep 2020 10:17:20: Tiny biologic drug to fight COVID-19 shows promise in animal models

Wed, 16 Sep 2020 07:24:27: After axing leading program, Unity now takes the ax to staff